Seagen Inc. (SGEN) Social Stream



Seagen Inc. (SGEN): $228.74

0.16 (-0.07%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add SGEN to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#103 of 344

in industry

SEAGEN INC (SGEN) Price Targets From Analysts

Use the tables below to see what analysts covering SEAGEN INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-01-12 13 $210 $153 $182.846 $228.74 -20.06%
2022-01-18 13 $210 $153 $182.615 $228.74 -20.16%
2022-01-21 14 $210 $153 $182.615 $228.74 -20.16%
2022-01-31 14 $210 $153 $182.384 $228.74 -20.27%
2022-02-07 13 $210 $153 $182.384 $228.74 -20.27%
2022-02-09 13 $210 $153 $180.769 $228.74 -20.97%
2022-02-11 13 $198 $150 $168.25 $228.74 -26.44%
2022-03-24 12 $195 $145 $162.5 $228.74 -28.96%
2022-04-22 11 $195 $145 $162.75 $228.74 -28.85%
2022-05-02 12 $195 $145 $162.75 $228.74 -28.85%
2022-05-16 12 $195 $145 $162.583 $228.74 -28.92%
2022-05-23 11 $195 $145 $163.454 $228.74 -28.54%
2022-06-14 11 $195 $145 $163.818 $228.74 -28.38%
2022-06-21 11 $208 $145 $170.909 $228.74 -25.28%
2022-07-27 14 $220 $145 $176.571 $228.74 -22.81%
2022-07-29 15 $220 $145 $179.333 $228.74 -21.6%
2022-08-01 15 $220 $150 $183.285 $228.74 -19.87%
2022-08-13 15 $220 $150 $184 $228.74 -19.56%
2022-08-15 16 $220 $150 $183.533 $228.74 -19.76%
2022-08-16 16 $220 $150 $184.133 $228.74 -19.5%
2022-09-17 16 $220 $150 $184.666 $228.74 -19.27%
2022-10-11 16 $220 $150 $185.266 $228.74 -19.01%
2022-10-12 16 $220 $150 $184.533 $228.74 -19.33%
2022-10-21 15 $220 $150 $184.533 $228.74 -19.33%
2022-10-27 15 $220 $150 $181.933 $228.74 -20.46%
2022-10-28 16 $200 $147 $174.8 $228.74 -23.58%
2022-10-31 16 $200 $136 $170.062 $228.74 -25.65%
2022-11-02 16 $200 $136 $166.687 $228.74 -27.13%
2022-11-29 17 $200 $135 $161.187 $228.74 -29.53%
2023-01-04 17 $188 $135 $160.25 $228.74 -29.94%
2023-01-19 17 $188 $135 $160.375 $228.74 -29.89%
2023-01-24 17 $188 $135 $160.312 $228.74 -29.92%
2023-01-30 18 $188 $135 $160.882 $228.74 -29.67%
2023-02-08 18 $188 $135 $159.647 $228.74 -30.21%
2023-02-14 17 $185 $135 $159.058 $228.74 -30.46%
2023-02-15 17 $185 $135 $158.823 $228.74 -30.57%
2023-02-17 18 $185 $135 $161.058 $228.74 -29.59%
2023-02-21 19 $180 $136 $162.722 $228.74 -28.86%
2023-02-23 20 $180 $136 $162.555 $228.74 -28.93%
2023-02-28 20 $210 $136 $164.526 $228.74 -28.07%
2023-03-07 20 $210 $136 $165.578 $228.74 -27.61%
2023-03-13 20 $229 $136 $168.789 $228.74 -26.21%
2023-03-14 20 $229 $136 $180.947 $228.74 -20.89%
2023-03-15 20 $229 $142 $188.736 $228.74 -17.49%
2023-03-19 20 $229 $142 $192.789 $228.74 -15.72%
2023-03-21 20 $229 $142 $197.21 $228.74 -13.78%
2023-04-28 20 $229 $142 $200.315 $228.74 -12.43%
2023-05-01 20 $229 $142 $204.105 $228.74 -10.77%
2023-05-03 20 $229.001 $142 $204.105 $228.74 -10.77%
2023-06-05 18 $229.001 $142 $206.944 $228.74 -9.53%
2023-08-11 18 $229 $142 $208.823 $228.74 -8.71%
2023-10-23 18 $229 $142 $213.176 $228.74 -6.8%
2023-11-06 17 $229 $142 $212.187 $228.74 -7.24%
2023-11-07 18 $229 $142 $212.187 $228.74 -7.24%

The Trend in the Analyst Price Target


Over the past 29 months, SGEN's average price target has gone up $23.06.

Over the past 44 weeks, SGEN's average upside potential has been 3.05%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-01-30 18 188 135 160.882 139.98 14.93%
2023-03-15 20 229 142 188.736 199.94 -5.6%
2023-04-04 20 229 142 200.315 204.89 -2.23%
2023-11-07 17 229 142 214.333 213.95 0.18%
2023-11-07 16 229 142 212.187 213.95 -0.82%

SGEN Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2.39 5 1 12 0 0 18

The Trend in the Broker Recommendations


SGEN's average broker recommendation rating worsened by 0.49 over the prior 16 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SGEN as an investment opportunity.

  • To contextualize these metrics, consider that out of all US stocks, SEAGEN INC's upside potential (average analyst target price relative to current price) is higher than 529.28% of them.
  • In terms of how SEAGEN INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 5968.09% of that group.
  • In the context of Pharmaceutical Products stocks, SEAGEN INC's number of analysts covering the stock is higher than 5786.35% of them.
  • In the context of Pharmaceutical Products stocks, SEAGEN INC's variance in analysts' estimates is lower than -1324.84% of them.

Stocks similar to SEAGEN INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are NVAX, NBIX, and GILD.

What is the outlook for SGEN? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!